Form 8-K - Current report:
SEC Accession No. 0001144204-13-043586
Filing Date
2013-08-07
Accepted
2013-08-07 15:47:01
Documents
3
Period of Report
2013-08-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT v352228_8k.htm 8-K 15397
2 PRESS RELEASE v352228_ex99-1.htm EX-99.1 86857
4 GRAPHIC header.jpg GRAPHIC 13910
  Complete submission text file 0001144204-13-043586.txt   122800
Mailing Address 425 METRO PLACE NORTH SUITE 300 DUBLIN OH 43017
Business Address 425 METRO PLACE NORTH SUITE 300 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000810509 (see all company filings)

EIN.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35076 | Film No.: 131017396
SIC: 2835 In Vitro & In Vivo Diagnostic Substances